isoplexis.comHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $161.52MM
IsoPlexis is building solutions to accelerate the development of curative medicines and personalized therapeutics.
Company | Sector | IPO Date | IPO Price/Share | Price/Share as of 3/17/23 | Since IPO |
IsoPlexis | Healthcare | 10/8/2021 | $15 | $0.74 | -95.1% |
Round Date | Series | Amount Raised | Post Money Valuation | Price/Share | Lead Investors | Since IPO |
1/21 | D | $92.5M | $348.2M | $76.92 | Perceptive Advisors, Ally Bridge Group, BlackRock | -99.0% |
1/20 | C-2 | $24.9M | $144.9M | $48.52 | Northpond Ventures, Spring Mountain Capital, Connecticut Innovations, Ironwood Capital, North Sound Ventures | -98.5% |
1/20 | C | $25.0M | $144.9M | $44.30 | Northpond Ventures, Spring Mountain Capital, Connecticut Innovations, Ironwood Capital, North Sound Ventures | -98.3% |
9/17 | B-2 | $7.0M | $49.1M | $29.64 | Spring Mountain Capital, Connecticut Innovations, Ironwood Capital, North Sound Ventures | -97.5% |
9/17 | B | $6.6M | $49.1M | $17.67 | Spring Mountain Capital, Connecticut Innovations, Ironwood Capital, North Sound Ventures | -95.8% |
5/15 | A-2 | $3.6M | $12.5M | $12.59 | Undisclosed Investors | -94.1% |
7/14 | A | $1.6M | $4.1M | $6.51 | Undisclosed Investors | -88.6% |